CHARGED ALPHATMFrontier AI stock research

BTSG · NasdaqGS

BrightSpring Health Services, Inc.

Health Information Services · United States

USD 72.620.2% daily changeQuote 2026-11-11 · USD
Market cap (USD)
US$14.45B
Trailing P/E
51.50x
Forward P/E
29.89x
Quarterly revenue growth
26.4%
Trailing net margin
2.7%
Indicated dividend yield
—

Snapshot 2026-11-11 · Latest financial period 2026-09-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Company background

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Company website

Q2 2026

Go beyond the headline.

BrightSpring (BTSG): Adj EBITDA +44%, Stock FELL 15% | Q2 2026

Published 2026-07-31

Comparable businesses

BTSG peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricBTSGBrightSpring Health Services, Inc.Snapshot 2026-11-11Financial period: 2026-09-30TEMTempus AI, Inc.Snapshot 2026-11-11Financial period: 2026-09-30HNGEHinge Health, Inc.Snapshot 2026-11-11Financial period: 2026-09-30Peer medianSimilar-size peers only
Market capMarket value, converted to USDUS$14.45BUS$14.49BUS$9.89BUS$12.19Bn=2
Forward P/EProvider forward earnings estimate29.89x—37.39x—
EV / EBITDAEnterprise value / trailing EBITDA24.04x—63.73x—
Revenue growthLatest quarter vs prior-year quarter26.4%23.1%52.4%37.8%n=2
Operating marginLatest reported quarter3.5%-18.5%18.8%0.1%n=2
Free cash flow yieldTrailing cash flow / market cap7.7%0.3%3.2%1.7%n=2
Net debt / EBITDANet debt / trailing EBITDA2.39x—-1.70x—
Debt / equityTotal debt / positive book equity1.09x2.86x0.11x1.49xn=2
Trailing P/ETrailing twelve-month earnings51.50x—32.99x—
Price / bookPrice / positive book equity per share6.91x28.89x33.01x30.95xn=2
EV / salesEnterprise value / trailing revenue1.09x10.26x12.18x11.22xn=2
Earnings growthLatest quarter vs prior-year quarter82.0%———
Gross marginTrailing twelve months12.5%64.5%85.8%75.1%n=2
Net marginTrailing twelve months2.7%-12.5%21.0%4.2%n=2
Return on equityProvider trailing return; positive equity only15.5%-37.5%47.6%5.0%n=2
Free cash flow marginTrailing free cash flow / revenue7.3%2.7%39.2%21.0%n=2
Dividend yieldIndicated annual dividend / price————
Earnings payoutProvider trailing dividend payout0.0%—0.0%—
Current ratioCurrent assets / current liabilities1.62x2.60x1.04x1.82xn=2
BetaProvider historical market sensitivity1.783.61——

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-11-11. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for BTSG

All available reporting periods
Q2 20262026-07-31

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.